Biology Reference
In-Depth Information
Danis, K., Baka, A., Lenglet, A., Van Bortel, W., Terzaki, I., Tseroni, M., et al., 2011. Autoch-
thonous Plasmodium vivax malaria in Greece. Euro Surveillance: Bulletin Europeen Sur
Les Maladies Transmissibles (European Communicable Disease Bulletin) 16 (42).
Danis-Lozano, R., Rodriguez, M.H., Betanzos-Reyes, A.F., Hernandez-Avila, J.E.,
Gonzalez-Ceron, L., Mendez-Galvan, J.F., et al., 2007. Individual risk factors for
Plasmodium vivax infection in the residual malaria transmission focus of Oaxaca,
Mexico. Salud Publica De Mexico 49 (3), 199-209.
Dapeng, L., Leyuan, S., Xili, L., Xiance, Y., 1996. A successful control programme for falci-
parum malaria in Xinyang, China. Trans. R. Soc. Trop. Med. Hyg. 90 (2), 100-102.
Department of Health, Executive Yuan, 1991. Malaria Eradication in Taiwan. Taipei, Taiwan.
Derbyshire, E.R., Mota, M.M., Clardy, J., 2011. The next opportunity in anti-malaria drug
discovery: the liver stage. PLoS Pathog. 7 (9), e1002178.
Doi, H., Kaneko, A., Panjaitan, W., Ishii, A., 1989. Chemotherapeutic malaria control opera-
tion by single dose of Fansidar plus primaquine in North Sumatra, Indonesia. Southeast
Asian J. Trop. Med. Public Health 20 (3), 341-349.
Dola, S., 1974. Mass drug administration as a supplementary attack measure in malaria eradi-
cation programme. East Afr. Med. J. 51 (7), 529-531.
Escudie, A., Hamon, J., Schneider, J., Mar-Apr 1962. Resultats d'une chimioprohylaxie
antipaludique de masse par l'association amino-4-quinoleine/amino-8-quinoleine en
milieu rural Africain de la region de Bobo-Dioulasso. Med. Trop. 22, 268-305.
Faust, E.C., Scott, J.A., Mc, D.G., 1947. Malaria mortality and morbidity in the United States
for the year 1945. J. Natl. Malar. Soc. 6 (3), 184-191.
Feachem, R., Sabot, O., 2008. A new global malaria eradication strategy. Lancet.
Feachem, R.G., Phillips, A.A., Targett, G.A., Snow, R.W., 2010. Call to action: priorities for
malaria elimination. Lancet 376 (9752), 1517-1521.
Field, J., Niven, J., Hodgkin, E., Mitchell, J., 1940. Field observations on the effects of pro-
phylactic plasmoquine on the incidence, course, severity and transmission of P vivax
malaria. Kuala Lumpur: Contract No.: 3.
Ganczakowski, M., Town, M., Bowden, D.K., Vulliamy, T.J., Kaneko, A., Clegg, J.B., et al.,
1995. Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with
malaria endemicity in the Vanuatu archipelago (southwestern Pacific). Am. J. Hum.
Genet. 56 (1), 294-301.
Garfield, R.M., Vermund, S.H., 1983. Changes in malaria incidence after mass drug admin-
istration in Nicaragua. Lancet 2 (8348), 500-503.
Garfield, R.M., Prado, E., Gates, J.R., Vermund, S.H., 1989. Malaria in Nicaragua: commu-
nity-based control efforts and the impact of war. Int. J. Epidemiol. 18 (2), 434-439.
Garrison, P.L., Hankey, D.D., Coker, W.G., Donovan, W.N., Jastremski, B., Coatney, G.R.,
et al., 1952. Cure of Korean vivax malaria with pamaquine and primaquine. J. Am. Med.
Assoc. 149 (17), 1562-1563.
Genton, B., D'Acremont, V., Rare, L., Baea, K., Reeder, J.C., Alpers, M.P., et al., 2008.
Plasmodium vivax and mixed infections are associated with severe malaria in children: a
prospective cohort study from Papua New Guinea. PLoS Med. 5 (6), e127.
Gething, P.W., Smith, D.L., Patil, A.P., Tatem, A.J., Snow, R.W., Hay, S.I., 2010. Climate
change and the global malaria recession. Nature 465 (7296), 342-345.
Goodwin Jr., M.H., 1950. Observations on the recession of malaria in an area of southwest-
ern Georgia. Am. J. Trop. Med. Hyg. 30 (5), 651-661.
Greenwood, B., 2004. The use of anti-malarial drugs to prevent malaria in the population of
malaria-endemic areas. Am. J. Trop. Med. Hyg. 70 (1), 1-7.
Greenwood, B., 2007. Intermittent preventive antimalarial treatment in infants. Clin. Infect.
Dis. 45 (1), 26-28.
Greenwood, B., 2008a. Progress in malaria control in endemic areas. Travel Med. Infect. Dis.
6 (4), 173-176.
Search WWH ::




Custom Search